BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...

Shares of Altria Group dipped 0.3% to $52.51. The cigarette manufacturer reported earnings of $1.29 a share on revenue of ...

The Biden administration never finalized a ban on menthol cigarettes, and the Trump administration withdrew the proposal. The ...

The Trump administrations removed FDA's plan to ban menthol cigarettes. The Biden administration did not finalize the rule ...

A government website shows the Trump administration has withdrawn the Food and Drug Administration’s proposed ban of menthol-flavored ...

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...

Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...

Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Thursday, January 30, 2025, at 9:00 a.m. Eastern Time to discuss its 2024 fourth-quarter and full-year business results. Altria ...

Altria Group, Inc. (Altria ... at 21:00 A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University ...